Skip to Content
Merck
CN
  • Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism.

Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism.

Acta dermato-venereologica (2012-01-27)
Agneta Gånemo, Mette Sommerlund, Anders Vahlquist
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
9-cis-Retinoic acid, ≥98% (HPLC)